user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 468459 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

Bearish Moving Average Cross by Auxilium Pharmaceuticals (AUXL)

Published on Thu, 03/28/2013 - 11:13
By Adrienne Chilton

Today, shares of Auxilium Pharmaceuticals (NASDAQ:AUXL) have fallen below their 10-day MA of $17.47 on a volume of 173K shares. Swing traders may find an opportunity for a short position, as such a crossover often suggests lower prices in the near term.

There is potential upside of 38.7% for shares of Auxilium Pharmaceuticals based on a current price of $17.30 and an average consensus analyst price target of $24.00. The stock should find initial resistance at its 50-day moving average (MA) of $17.77 and further resistance at its 200-day MA of $21.20.

Over the past year, Auxilium Pharmaceuticals has traded in a range of $16.25 to $29.37 and is now at $17.30, 6% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.4% while the 200-day MA has slid 0.3%.

Auxilium Pharmaceuticals Inc. develops and commercializes pharmaceutical products that target urologic and sexual health disorders. The company's marketed product ,TESTIM, is a proprietary, topical 1% testosterone gel indicated for the treatment of hypogonadism.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Booz Allen Hamilton Fulfills the Promise...

Booz Allen Hamilton was upgraded from Market Perform to Outperform by Cowen and Company ...

Analyst Rating In Review: DigitalGlobe S...

DigitalGlobe was upgraded from Neutral to Overweight by JP Morgan one week ago. The st ...

Analyst Rating In Review: Sunstone Hotel...

One week ago Sunstone Hotel Investors (NYSE:SHO) was upgraded from Hold to Buy at ISI G ...

Analyst Rating In Review: Barrick Gold S...

One week ago Barrick Gold (NYSE:ABX) was upgraded from Underweight to Neutral at HSBC. ...

HSBC Made the Right Call, POSCO 1.5% Low...

A week ago, HSBC downgraded POSCO from Overweight to Neutral. POSCO shares are selling ...

Abaxis Up 4.9% Since Canaccord Genuity U...

One week ago Abaxis (NASDAQ:ABAX) was upgraded from Hold to Buy at Canaccord Genuity. ...

Cowen and Company Made the Right Call, C...

CVS Caremark was upgraded from Market Perform to Outperform by Cowen and Company one we ...

Analyst Rating Flashback: Symantec Down ...

Symantec was downgraded from Outperform to Sector Perform by RBC Capital one week ago. ...